Navigating neurological disorders: harnessing the power of natural compounds for innovative therapeutic breakthroughs.

animal sources marine sources natural compounds neurological disorders neuroprotection

Journal

EXCLI journal
ISSN: 1611-2156
Titre abrégé: EXCLI J
Pays: Germany
ID NLM: 101299402

Informations de publication

Date de publication:
2024
Historique:
received: 03 02 2024
accepted: 07 03 2024
medline: 14 5 2024
pubmed: 14 5 2024
entrez: 14 5 2024
Statut: epublish

Résumé

Novel treatments are needed as neurological issues become more frequent worldwide. According to the report, plants, oceans, microorganisms, and animals contain interesting drug discovery compounds. Alzheimer's, Parkinson's, and stroke reviews emphasize neurological disorders' complexity and natural substances' safety. Learn about marine-derived and herbal substances' neuroprotective characteristics and applications. Molecular pathways show these substances' neurological healing effects. This article discusses clinical usage of Bryostatin-1, Fucoidan, Icariin, Salvianolic acid, Curcumin, Resveratrol, etc. Their potential benefits for asthma and Alzheimer's disease are complex. Although limited, the study promotes rigorous scientific research and collaboration between traditional and alternative medical practitioners. Unexplored natural compounds, quality control, well-structured clinical trials, and interdisciplinary collaboration should guide future study. Developing and employing natural chemicals to treat neurological illnesses requires ethical sourcing, sustainability, and public awareness. This detailed analysis covers natural chemicals' current state, challenges, and opportunities in neurological disorder treatment. See also the graphical abstract(Fig. 1).

Identifiants

pubmed: 38741726
doi: 10.17179/excli2024-7051
pii: 2024-7051
pmc: PMC11089094
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

534-569

Informations de copyright

Copyright © 2024 Rushendran et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Auteurs

Rapuru Rushendran (R)

Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur- 603 203, Tamil Nadu, India.

Rukaiah Fatma Begum (RF)

Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur- 603 203, Tamil Nadu, India.

Ankul Singh S (A)

Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur- 603 203, Tamil Nadu, India.

Pavithra Lakshmi Narayanan (PL)

Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur- 603 203, Tamil Nadu, India.

Chitra Vellapandian (C)

Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur- 603 203, Tamil Nadu, India.

Bhupendra G Prajapati (BG)

Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Kherva, 384012, Gujarat, India.

Pijush Kumar Paul (PK)

Department of Pharmacy, Gono Bishwabidyalay University, Mirzanagar, Savar, Dhaka-1344, Bangladesh.

Classifications MeSH